Furthermore, 5-LO expression was up-regulated upon inhibition of central cell cycle–promoting factors such as CDK4/6 (palbociclib) and E2F1, whereas overexpression of b-Myb attenuated 5-LO levels in the colon cancer cells. Here, CDK4 is linked to malignant colon neoplasm.